What You Ought to Know
- Theranica introduced the publication of a peer-reviewed compatibility study within the Journal of Clinical Medicine. The research demonstrated that the Nerivio Remote Electrical Neuromodulation (REN) wearable could be safely used concurrently widespread Steady Glucose Monitoring (CGM) methods.
- The concurrent use of those units doesn’t disrupt glucose measurement accuracy.
- In the USA, an estimated 4.5 million folks reside with each diabetes and migraines. The research evaluated 21 adults utilizing Nerivio alongside Abbott FreeStyle Libre and Dexcom methods.
- Outcomes confirmed a median glucose studying deviation of just one.6%, which is nicely under the predefined 5.0% threshold. Researchers noticed zero Bluetooth disruptions, missed information transmissions, machine malfunctions, or adversarial occasions throughout the research.
Managing Migraines and Diabetes
This technical validation addresses an enormous affected person inhabitants. Globally, a whole bunch of hundreds of thousands of adults and adolescents are affected by migraines and diabetes. In the USA alone, an estimated 4.5 million people reside with each situations.
Many of those sufferers depend on wi-fi CGM methods (just like the Abbott FreeStyle Libre or Dexcom units) that transmit steady blood-glucose measurements to smartphone apps by way of Bluetooth. As a result of the Nerivio wearable can also be managed and monitored by a smartphone app utilizing Bluetooth, sufferers and suppliers have ceaselessly questioned whether or not the 2 applied sciences might safely coexist.
“Migraine therapy could be particularly complicated for people with diabetes as a result of many pharmacologic choices carry metabolic or cardiovascular concerns,” famous Dr. Richelle deMayo, chief medical info officer at Connecticut Kids’s Analysis Institute and a contributing writer of the research. “As linked well being applied sciences proceed to develop, confirming secure multi-device operation is more and more essential for real-world affected person care.”
The Medical Information
The repeated-measures interventional compatibility research evaluated 21 adults with diabetes. The members used their CGM methods concurrently with a Nerivio device throughout a full 45-minute REN session.
Researchers in contrast the glucose measurements taken throughout energetic Nerivio stimulation towards these taken when the stimulation was paused. The research focused a stringent predefined imply absolute relative distinction (MADR) threshold of 5.0%.
The outcomes have been extremely favorable:
- The median deviation was just one.6%, nicely under the prespecified 5.0% benchmark.
- Abbott FreeStyle Libre customers demonstrated a median deviation of 1.0%.
- Dexcom customers demonstrated a median deviation of 1.7%.
- The research noticed no Bluetooth disruptions, co-interference, or missed information transmissions.
- There have been no machine malfunctions or adversarial occasions reported.
The authors conclude that simultaneous use of Nerivio and CGM methods is secure, possible, and functionally suitable, serving to take away a key barrier to integrating a number of wearable applied sciences for folks managing comorbid migraine and diabetes.
